GlassScriptPhysician profile
Danielle Marie Long
NPI 1487294898
$1,518.00
in general payments reported to CMS, 2019-2025
17 companies · $722 in 2025
The $722 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $257 · 2024: $539 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $318.69 | 2024-2025 | |
| Novo Nordisk INC | $194.54 | 2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $156.82 | 2024-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $134.20 | 2024-2025 | Zepbound, Mounjaro, Emgality |
| E.R. Squibb & Sons, L.L.C. | $132.63 | 2023 | Eliquis |
| Amgen INC. | $130.82 | 2024-2025 | Otezla, Repatha, Repatha |
| Viiv Healthcare Company | $124.46 | 2023 | Dovato |
| Novartis Pharmaceuticals Corporation | $68.83 | 2025 | |
| Pfizer INC. | $43.51 | 2024-2025 | |
| Exact Sciences Corporation | $40.52 | 2025 | Cologuard Collection Kit |
| Viatris Specialty LLC | $38.78 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.37 | 2025 | Jardiance |
| Abiomed | $25.27 | 2024 | Impella |
| Otsuka America Pharmaceutical, INC. | $19.49 | 2025 | Rexulti |
| Vivus LLC | $19.28 | 2024 | Pancreaze |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $16.54 | 2025 | Ohtuvayre |
| Intra-Sana Laboratories | $15.25 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.